These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3738260

  • 1. [Control of the resistance of gram-negative bacilli to aminoglucosides. Results of a 3-year prospective study with the exclusive use of amikacin].
    Ruiz-Palacios G, Ponce de León S, Sifuentes J, Ponce de León S, Calva J, Huazano F, Ontiveros C, Ojeda F, Bobadilla M.
    Rev Invest Clin; 1986; 38(1):1-6. PubMed ID: 3738260
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amikacin.
    Gleckman R.
    Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J, Thomas M, Shanmugam J.
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Aspects of antibacterial therapy using amikacin].
    Grassi GG, Bucci R, Ferrara A.
    G Ital Chemioter; 1976 Apr; 23(1):47-54. PubMed ID: 1029696
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Amikacin in the child: efficacy, tolerance, effects on the intestinal microbial ecosystem].
    Mathieu H, Lambert-Zechovsky N, Beaufils F, Blum C, Binger E, Guillot M.
    Nouv Presse Med; 1979 Oct 31; 8(42):3482-91. PubMed ID: 537901
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical and laboratory evaluation of amikacin].
    Borowski J, Musierowicz A, Dzierzanowska D, Niedźwiecka M, Gruszecki W.
    Pol Tyg Lek; 1979 Oct 29; 34(44):1721-5. PubMed ID: 514892
    [No Abstract] [Full Text] [Related]

  • 17. [Sensitivity of gram-negative germs to Amikacin].
    Redjeb SB, Ennaifer M, Bissardon O, Ben Salah N, Boujnah A.
    Tunis Med; 1979 Oct 29; 57(2-3):103-6. PubMed ID: 553336
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Amikacin, in association, in severe infections due to Gram-negative bacteria].
    Dureux JB, Canton Ph, Etienne Y, Neiman L.
    Nouv Presse Med; 1979 Oct 31; 8(42):3492-5. PubMed ID: 537902
    [No Abstract] [Full Text] [Related]

  • 20. Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
    Tally FP, Louie TJ, O'Keefe P, Gorbach SL, Bartlett JG.
    J Infect Dis; 1976 Nov 31; 134 SUPPL():S428-32. PubMed ID: 993634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.